baber/WOPTO huggingface dataset:
Patent GB-1319905-A (GB)
Title: Multi-compartment packages
IPC: B65D75/30
Filed: 1971-07-28
Abstract: 1319905 Wallets JOHN DICKINSON & CO Ltd 28 July 1971 35358/71 Addition to 1024111 Heading A4G [Also in Division B8] A package wallet is formed of flexible sheet and comprises a plurality of pockets 18-20, 18'- 20' having their openings adjacent a fold line 23 whereby the pockets may be folded to lie flat on each other, each pocket being formed by a back wall 10, 11 of opaque or semi-opaque web e.g. paper, sealed at 21, 14, 15, 16, 17 to a transparent web 12, the back wall of at least one compartment e.g. 18', 19', 20' being extended at 22 to overlap the opening of one or more other compartments e.g. 18, 19, 20, when the package lies flat in an unfolded condition, the package being foldable away from the back walls along the fold line 23 so that the extension of compartments 18'-20' uncovers the openings of compartments 18-20. The package may be further folded along lines 16, 17.
Patent GB-1321514-A (GB)
Title: Purification of waste waters
IPC: C02F11/12
Filed: 1971-04-19
Abstract: 1321514 Treating waste water A K HERR 19 April 1971 [7 April 1970] 26128/71 Heading C1C [Also in Division C3] A method of recovering fibrous solids suspended in waste water comprises flocculating the solids, mechanically dewatering the solids (e.g. to 50-75% by wt. moisture content), drying the dewatered solids (e.g. to 2-10% by wt. moisture content) and disintegrating the solids in presence of at least one additive. The additive which may be boric acid (as flame suppressing agent), phosphate, silicate, insecticide or fungicide, may be added prior to flocculation, after drying or during disintegration. A binding agent may be added prior to disintegration. The drying step may sterilize the solids. The solids may be dewatered in a vacuum filter or centrifuge and disintegrated in a beater, toothed, plate disc, pin or impact plate mill. In a particular embodiment a paper mill waste water comprising cellulose fibres, pigments and minerals is flocculated with metal salts and lime. The sludge is allowed to settle. The supernatant liquid may be aerobically or anaerobically treated. The sludge is dewatered in a rotary filter and thermally dried. Boric acid is added and the mixture is disintegrated in an impact plate mill. The product is incorporated in wood chips for the production of chipboard.
Patent GB-1334844-A (GB)
Title: Selector valves for nuclear reactors
IPC: G21C17/04
Filed: 1969-08-27
Abstract: 1334844 Valves REYROLLE PARSONS Ltd 25 Nov 1970 [27 Aug 1969] 42596/69 Heading F2V A gas sampling valve for a nuclear reactor has a selector 32 which is rotated stepwise to connect each of a ring of ports 36 in turn to a central outlet port 37. The selector is loosely received in a rotor 27, 29 rotatably supported by carbon bearings 28, and includes radial pins 30 spaced at the same angular pitch as ports 36. The stepwise rotation is effected by reciprocation of a member 24 having opposed teeth 25, 26 which co-operate with pins 30 to index the selector 32 from one port 36 to the next during cycle of movement of member 24. The latter is reciprocated by successively pressurizing and evacuating bellows 18. The selector 32 is suitably of carbon or ceramic material.
Patent GB-1335883-A (GB)
Title: Exothermic composition for hot tops
IPC: C10L5/40
Filed: 1971-09-21
Abstract: 1335883 Exothermic composition SHINTO KOGYO KK 21 Sept 1971 [10 Sept 1971] 42334/71 Heading C5G A powdered exothermic hot top composition contains 5 to 30 wt. per cent, based on the weight of the composition, of fibres having lengths between 0À5 and 30 mm. These fibres may be natural or synthetic, inorganic or organic, e.g. asbestos, amosite, glass or slag wool, paper, wood pulp, bagasse or beans. The exemplified compositions contain powdered aluminium and aluminium ash, fluorspar, sodium nitrate, iron oxide in addition to the fibres.
Patent GB-1339121-A (GB)
Title: Vapour vacuum pumps
IPC: F04F9/00
Filed: 1972-04-26
Abstract: 1339121 Vapour vacuum pumps BRITISH OXYGEN CO Ltd [trading as EDWARDS HIGH VACUUM INTERNATIONALI 26 April 1972 19381/72 Heading F1E A vapour vacuum pump has an inlet valve 12 from which the housing flares outwardly to a portion of maximum diameter then inwardly to join a cylindrical portion 26 the internal diameter of which is approximately equal to that of the valve opening. A baffle assembly is located in the portion of maximum diameter and includes a nozzle cap 52 and skirt 54, the cap supporting the upper nozzle part 40 by devices 56, 58 and spring 41; the cap in turn is supported by a strap (84) from the housing. The outlet 18 has a separate cold trap 20, the outlet 22 from which is connected to a valve (88), Fig. 2, (not shown), which is also connected by a pipe (76) to the pump inlet above the valve member, so that the outlet 22 and pipe (76) may be connected to the backing/roughing pump.
Patent GB-1341546-A (GB)
IPC: B60P3/34
Filed: 1969-12-30
Abstract: 1341546 Vehicle bodies T L WHITEHEAD 19 April 1971 [30 Dec 1969 30 May 1970] 63212/69 and 26205/70 Heading B7B Additional covered spaces are provided in a motor vehicle for use as holiday accommodation by collapsible canopies 4 associated with flaps 2 which are hinged at the lower edges of apertures in each side of the vehicle body and are movable between an upright stowed position and a horizontal operative position. Each flap 2 is supported in the operative position by a bar 2a which is part of a frame reinforcing the aperture, and by chains 3. Each canopy 4 comprises a canvas cover supported by one or more plastics hoops. The flaps 2 may be of single bed size and may be fitted with a foam rubber mattress. The flaps may alternatively be fitted at floor level to form extensions of the vehicle floor when in the horizontal position.
Patent GB-1345628-A (GB)
Title: Indenyl acetates
IPC: C07C317/00
Filed: 1971-12-22
Abstract: 1345628 Indenyl acetates MERCK & CO Inc 22 Dec 1971 59782/71 Heading C2C Novel compounds (I) where X is C 1-6  alkoxy or halo, X<SP>1</SP> and X<SP>11</SP> are H or halo, Y is H or C 1-6  alkyl, Z is p-methylsulphinylbenzylidenyl, A is H, C 1-6  alkyl, C 1-6  haloalkyl or aryl and B is acyl, are made, e.g. by acylation techniques. Pharmaceutical preparations exhibiting antiinflammatory, anti-pyretic and analgesic activities contain (I) as active ingredient. Administration is orally, parenterally, rectally and topically.
Patent GB-1349745-A (GB)
Title: Rotary positive displacement machines
IPC: F04B19/02
Filed: 1970-06-12
Abstract: 1349745 Rotary positive-displacement machines MEGATOR PUMPS & COMPRESSORS Ltd 26 May 1971 [12 June 1970] 28617/70 Heading F1F A shoe 1 for a machine of the kind described in Specification 592432 has an elastomeric body 2 strengthened by a relatively rigid base 6 and U-shaped sides 7 made of e.g. a reinforced thermosetting resin. The base 6 engages with the port plate and thus may be made of a wear and abrasion resistant resin. The sides 7 may be made of a different resin. Bevelling at 10 permits angular deflection of the sides. Channel pieces 11 made of a relatively rigid material may be lodged in the ends of the body. The base, sides and channel pieces are united with the body during moulding of the latter. Alternatively, the base and the sides are secured by an adhesive.
Patent GB-1354496-A (GB)
Title: Imaging systems
IPC: H04N5/228
Filed: 1970-08-07
Abstract: 1354496 Television MULLARD Ltd 24 Sept 1971 [7 Aug 1970] 38271/70 Heading H4F To improve the quality of the signal output of an image pick-up tube, i.e. compensate for the beam current being too high for low contrast picture elements resulting in pseudodifferentiation, or too low for high contrast picture elements resulting in "coma", the amplitude of the signal output is sampled during a fraction of each picture element period and this amplitude is maintained for the rest of the picture element period. A "real-time" sample and hold circuit is used, its hold output being produced during the actual time that the signal output is sampled. Preferably the peak amplitude of the signal output is sampled and held, thus enabling the beam current to be increased which is particularly important in low framerate television systems. Alternately by sampling the signal output from a low frame-rate camera, transients picked up from the deflection system or control logic may be eliminated. To eliminate "coma" the beam current may be increased after the sample has been taken to a higher value for the remainder of the picture element period, a pseudo-random dot scan being preferably used. In standard television systems it is necessary to either modulate the beam current or wobble the line scan so as to break up the horizontal format. Examples of the "real-time" sample and hold circuits are given.
Patent ID-26227-A (ID)
Inventor: CRUPPER RANDOLPH SCOTT
IPC: G11B7/125
Filed: 1997-01-02
Abstract: The optical drive system described comprises an optical assembly, a light source, an objective lens disposed in an objective lens subassembly, an actuator assembly which suspends the objective lens subassembly for relative motion thereof with respect to the actuator assembly, first and second servomotors for moving the objective lens subassembly in tracking and focusing directions, respectively, relative to the actuator assembly, a third servomotor for moving the actuator assembly in the tracking direction relative to a medium, first electronic means for controlling the first, second, and third servomotors, a motor with a hub assembly for moving the medium relative to the objective lens subassembly, a photo detector, second electronic means responsive to an output signal of the photo detector for decoding information carried in the light returning from the medium, third electronic means for enabling the light source to emit light at a first intensity level to encode information on the medium and at a second intensity level to read information encoded thereon, data receiving means for accepting data that is storable on the medium, data encoding means being responsive to the data receiving means for representing the data to be stored in a predetemined format, the data encoding means also for directing data to the third electronic means, a magnetic field generator for producing a magnetic field on a portion of the medium and for coacting with the third electronic means and the light source to write and erase information on the medium, a cartridge loading assembly, servo error detecting means coupled to the first electronic means, and a housing structure for positioning components of the optical drive system with respect to one another.The system claimed include means to monitor and use a Quad Sum signal associated with the return light for focus capture.
Patent IL-118528-A (IL)
Title: Pharmaceutical compositions containing 2, 8- disubstituted dihydronaphthylene and similar compounds for treatment of rheumatoid arthritis
IPC: C07C205/57
Filed: 1996-06-02
Abstract: A pharmaceutical composition for treating rheumatoid arthritis in a mammal comprising a therapeutically effective amount of a compound of the formula or a nontoxic pharmaceutically acceptable salt, physiologically hydrolyzable ester or solvate thereof, in which X is -O-CO-, -NH-CO-, -CS-NH-, -CO-O-, -CO-NH-, -COS-, -SCO-, -SCH2-, -CH2-CH2-, -C:C-, 59 ז' באייר התשס" א - April 30, 2001 -CH2-NH-, -COCH2-, NHCS-, -CH2S-, -CH2O-, -OCH2-, -NHCH2- or -CR5=CR6-; Rm and Rk are independently hydrogen, halogen, C1-6 alkyl, hydroxy, C1-C6 alkyloxy or nitro; n is zero or one; R4 is -(CH2)t - Y, C1-6 alkyl, or C3-6 cycloalkyl; R1 is -CO2Z, C1-6 alkyl, CH2OH, -CONHRy, or CHO; R2 and R3 are independently hydrogen or C1-6 alkyl; Ra and Rb are independently hydrogen or C1-6 alkyl; but when n is one, Ra and Rb together can form a radical of the formula Y is naphthyl or phenyl, both radicals can be optionally substituted with one to three same or different C1-6 alkyl or halogen; Z is hydrogen or C1-6 alkyl; R5, R6 and Ry are independently hydrogen or C1-6 alkyl; and t is zero to six.
Patent IL-122780-A (IL)
Title: Bolt unit and frame arrangement
IPC: E05B65/48
Filed: 1996-06-26
Abstract: PCT No. PCT/GB96/01530 Sec. 371 Date Dec. 24, 1997 Sec. 102(e) Date Dec. 24, 1997 PCT Filed Jun. 26, 1996 PCT Pub. No. WO97/01690 PCT Pub. Date Jan. 16, 1997This invention relates to a bolt unit and frame arrangement. In particular it relates to a lockable bolt unit having a slidable bolt, typically for securing two moveable panels together or for securing one moveable panel to a fixed frame.
Patent IL-124094-A (IL)
Title: Process for the preparation of organic disulphides and polysulphides in the presence of polystyrene-divinyl benzene resins possessing primary amine groups
IPC: B01J31/06
Filed: 1996-12-03
Abstract: The preparation of organic disulphides and polysulphides by reaction of sulphur with a mercaptan or with a polysulphide of lower sulphur order in order to convert it into polysulphide of higher order, or alternatively by reaction of a mercaptan with an organic polysulphide of high sulphur order in order to convert it into polysulphide of lower sulphur order, in the presence of a catalyst in the form of a resin with a basic function, characterized in that the resin is based on polystyrene-divinylbenzene (PS-DVB) functionalized with primary amino groups and having the general formula (I):    <IMAGE>  (I)    <IMAGE>   being the PS-DVB resin support, L being a linear organic radical which is as long as or longer than the methylene radical (-CH2-).
Patent IL-131466-A (IL)
Title: Dispersible, metal oxidecoated, barium titanate materials
IPC: C04B35/468
Filed: 1998-02-12
Abstract: Barium titanate-based particles having a coating comprising a metal oxide, metal hydrous oxide, metal hydroxide or organic acid salt of a metal other than barium or titanium, wherein at least 90 percent of said coated particles have a particle size less than 0.9 micrometer.
Patent IL-138445-A (IL)
Title: Method for determining t-cell epitopes within a protein and method for reducing allergenicity of said protein
IPC: A61K38/46
Filed: 2000-09-13
Abstract: The present invention relates to a novel improved protein mutant which produces low allergenic response in humans compared to the parent of that mutant. Specifically, the present invention comprises neutralizing or reducing the ability of T-cells to recognize epitopes and thus prevent sensitization of an individual to the protein.
Patent IL-142231-A (IL)
Title: Antigenic composition comprising a selected antigen and a mutant cholera holotoxin as an adjuvant, a method of producing such mutant cholera holotoxin and use thereof in an antigenic composition
IPC: C07K14/28
Filed: 2001-03-25
Abstract: A mutant cholera holotoxin featuring a point mutation at amino acid 29 of the A subunit, wherein the glutamic acid residue is replaced by an amino acid other than aspartic acid, is useful as an adjuvant in an antigenic composition to enhance the immune response in a vertebrate host to a selected antigen from a pathogenic bacterium, virus, fungus or parasite. In a particular embodiment, the amino acid 29 is histidine. The mutant cholera holotoxin may contain at least one additional mutation in the A subunit at a position other than amino acid 29. The antigenic composition may include a second adjuvant in addition to the mutant cholera holotoxin.
Patent IL-142516-A (IL)
Title: Specific genetic modifications of trehalose-6-phosphate synthase for increased activity in eucariotic organisms
IPC: A01H5/10
Filed: 2001-04-10
Abstract: The present invention relates to a method for the preparation of a eukaryotic organism, for example selected from plants, animals and fungi, showing constitutive, inducible and/or organ specific expression of a specifically modified TPS gene, which comprises the steps of:     a) providing a TPS gene; b) designing a suitable modification to the TPS gene by aligning the gene with the corresponding gene of yeast and establishing which part of the gene extends beyond the 5' terminus of the yeast gene; c) deleting a part of the N-terminal region of the TPS gene extending beyond the 5' terminus of the yeast gene, preferably the complete extending part thereof, in order to achieve an increased trehalose-6-phosphate synthase activity; d) cloning the thus modified gene into an expression vector under the control of a constitutive, inducible and/or organ-specific promoter; e) transforming a plant cell or tissue with the thus obtained expression vector; and f) regenerating a complete plant from the transformed plant cell or tissue, wherein the plant is selected from Selaginella lepidophylla, Arabidopsis thaliana, rice, apple, sugar beet, sunflower (Helianthus annuus), tobacco (Nicotiana tabacum), soybean (Glycine max); and wherein the fungus is selected from Aspergillus niger, Agaricus bisporus, Pictia pastoris, Kluyveromyces lactis and methylotrophic yeasts, and wherein the animal is selected from mammalian and invertebrate cell cultures used for production of proteins and small molecules, invertebrate cells used for baculovirus expression. Furthermore, the present invention relates to plants having an increased stress tolerance and/or increased photosynthetic productivity and/or improved carbon partitioning in the whole plant or in specific plant parts and harboring in their genome said specifically modified TPS gene.   <IMAGE>
Patent IL-143724-A (IL)
Title: Chemical heat pump
IPC: C09K5/06
Filed: 1999-12-20
Abstract: In a chemical heat pump a substance is used which within the temperature range for which the heat pump is intended has a transition between a solid phase and a solution phase. The substance can for a solar driven chemical heat pump comprise magnesium chloride hexahdrate. In an accumulator part of the heat pump a heat exchanger (21) is provided enclosed by a net (23). The solid phase is primary located inside the net in contact with the heat exchanger while the solution phase flow out of the net and is collected in space (24') below the heat exchanger. From this space the solution phase is pumped and sprayed over the heat exchanger from a spray bar (25). Thereby, all the time equilibrium is maintained. The advantage including the constant temperature step and the relatively large energy content of solid substance is thereby combined with the high power of liquid substances. Such a chemical heat pump is among other things suitable for converting low grade heat energy such as solar energy to cooling and in some cases also for a simultaneous production of heat.
Patent IL-152131-A (IL)
Title: Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
IPC: A61K38/095
Filed: 2002-10-06
Abstract: The present invention relates to compositions and methods for the modulated release of one or more proteins or peptides. The composition is comprised of a biocompatible polymeric matrix, a protein and/or peptide, and a sparingly water-soluble or essentially insoluble particle. The protein is deposited by adsorption or some other mechanism onto the sparingly water-soluble biocompatible particle wherein the protein-particle combination is dispersed within the polymeric matrix. The deposition of the protein onto the particle acts to modulate the release of the protein or peptide from dosage forms including long-acting dosage systems.
Patent IL-160368-A (IL)
Title: Pack containing medicament and dispensing device
IPC: A61M15/00
Filed: 2004-02-12
Abstract: A pack containing medicament, the pack including a base having first and second opposing faces, at least one recess being formed in the first face, a foil secured to the first face so as to form with the at least one recess a sealed compartment for housing medicament and a substantially rigid member housed in the compartment extending generally from the second face to the first face such that the member can be pushed from the second face so as to rupture the foil outwardly of the compartment at the first face without compressing the medicament and a dispensing device for use with or including such a pack having an actuator for pushing the member from the second face so as to rupture the foil outwardly of the compartment at the first face.
Patent IL-174809-A (IL)
Title: Inhaler for delivery of a medicament
IPC: A61M15/00
Filed: 2006-04-05
Abstract: An inhaler (1) comprising a housing (2) to receive a blister (6a) having a puncturable lid (6c) and containing a dose of medicament for inhalation by a user is disclosed. It comprises a mouthpiece (5) through which a dose of medicament is inhaled by a user, a blister piercing member (7) comprising at least two discrete piercing heads (9) operable to pierce a corresponding number of holes in said blister, an actuator (3) comprising an arm pivotally mounted to the housing at one end, and an opening formed in the vicinity of each piercing head. At least one of said openings forms an airflow inlet into said blister and, at least one other of the openings forming an airflow outlet from said blister. The mouthpiece includes a primary chamber (31) having an outside air inlet (34) in communication, via the primary chamber, with the or each airflow inlet opening and, a secondary chamber (32) in communication with the or each airflow outlet opening. When a user inhales through the mouthpiece, air is drawn through the or each airflow inlet opening into the blister via the outside air inlet and the primary chamber to entrain the dose in the airflow, said entrained dose passing through the or each airflow outlet opening into the secondary chamber of the mouthpiece from where it is carried into the user's airway.
Patent IL-206009-A (IL)
Title: Screening methods for the identification and selection of inhibitors of formation of pyroglutamic acid
IPC: C07F9/572
Filed: 2010-05-27
Abstract: The present invention provides novel physiological substrates of mammalian glutaminyl cyclase (QC, EC 2.3.2.5), new effectors of QC, methods for screeing for such effectors, and the use of such effectors and pharmaceutical compositions comprising such effectors for the treatment of conditions that can be treated by modulation of QC-­activity. Preferred compositions additionally comprise inhibitors of DP IV or DP IV-like enzymes for the treatment or alleviation of conditions that can be treated by modulation of QC- and DP IV-activity.
Patent IL-206332-A (IL)
Title: Process for production of radioactive-fluorine-labeled organic compound
IPC: C07B/
Filed: 2010-06-13
Abstract: A process for production of a radioactive fluorine-labeled organic compound is provided which can improve the yield of radioactive fluorination. Provided is a process in which a compound represented by the following formula (1): (wherein R 1 is a straight or branched alkyl chain with 1-10 carbon atoms or an aromatic substituent, R 2 is a straight or branched haloalkylsulfonic acid substituent with 1-10 carbon atoms, a straight or branched alkylsulfonic acid substituent with 1-10 carbon atoms, a fluorosulfonic acid substituent or an aromatic, sulfonic acid substituent, and R 3 is a protective group) is heated under stirring in an inert organic solvent in a presence of a phase transfer catalyst, 16 F ions and potassium ions, so as to effect labeling with a radioactive fluorine, wherein the heating temperature is 40-90°C, and the concentration of the phase transfer catalyst in the inert organic solvent is 70 mmol/L or more. Preferably, the molar ratio of the phase transfer catalyst is 0.7 or more relative to the compound of the formula (1), and the concentration of the compound of the formula (1) in the inert organic solvent is 50 mmol/L or more.